(Q36614629)

English

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial.

scientific article published on May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

Alessandro Morabito

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Massimo Di Maio

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Nicola Normanno

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

C Pacilio

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

F Nuzzo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Gravina

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

V Labonia

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

G Landi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

E Rossi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

E De Maio

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

G D'Aiuto

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

C Gallo

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

F Perrone

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A de Matteis

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

NCI-Naples Breast Cancer Group

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

British Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

94

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1233-1236

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603096

0 references

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

30 September 2017

Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

30 September 2017

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

30 September 2017

Use of predictive probabilities in phase II and phase III clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

28 June 2018

Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy. A subset analysis of CALGB Study 8081.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

28 June 2018

Are anthracycline-taxane regimens the new standard of care in the treatment of metastatic breast cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

20 September 2018

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

20 September 2018

Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Prognostic factors in the response of a first line chemotherapy in advanced breast cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: a multicentric phase I-II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6603096

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36614629&oldid=2074952464"